Medicine

Is Low-Dose Lithium a Better Solution for Major Depression?

Some studies show it’s better than SSRIs—but there’s no incentive to invest in clinical trials.

By David Levine

Repurpose This Drug

How drugs that hit targets for depression and kidney disease could help people suffering physical pain.

By Caren Chesler

Alex Zhavoronkov: Live Long and Prosper

The maniacally focused founder of Insilico Medicine is going all in on AI to discover new medicines and extend lifespan.

By Matthew Hutson

Reproducibility in Clinical Trials is Like Trying to Catch a Rabbit by the Tail

Scientists are not routinely sloppy, clinicians don’t usually cheat, and clinical research is generally well designed. So why is it so hard to reproduce results?

By David Warmflash

Hot Competition

Surprising new science on the benefits of heat therapy for peak-performing athletes—and people in hospitals.

By Robin Donovan

Perspective: The Human Immunome Project is the Next Big Leap

An insider’s view of the effort to decode and model the entire immune system.

By Jane Metcalfe

New Tech for Gene Therapy Could Advance Longevity

Maybe the science is finally catching up with BioViva CEO Elizabeth Parrish.

By David Warmflash

More At-Home Tests Are Heading Your Way

A new wave of spit-and-swab home testing kits promises to give individuals more control over their own health.

By Emily Sohn

Perspective: Should I Get the New COVID-19 Bivalent Booster?

Our writer unpacks the data behind the new vaccines and wonders what happened to nuance in the CDC’s recommendations.

By David Warmflash

7 Lessons on Aging

The ARDD meeting in Copenhagen this month featured new money, old experiments, endless enthusiasm, and a palpable sense of possibility.

By Jason Socrates Bardi